Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins
- PMID: 19204029
- PMCID: PMC2690478
- DOI: 10.1074/mcp.M800443-MCP200
Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins
Abstract
Novel markers for prostate cancer (PCa) are needed because current established markers such as prostate-specific antigen lack diagnostic specificity and prognostic value. Proteomics analysis of serum from mice grafted with human PCa xenografts resulted in the identification of 44 tumor-derived proteins. Besides secreted proteins we identified several cytoplasmic proteins, among which were most subunits of the proteasome. Native gel electrophoresis and sandwich ELISA showed that these subunits are present as proteasome complexes in the serum from xenograft-bearing mice. We hypothesized that the presence of proteasome subunits and other cytoplasmic proteins in serum of xenografted mice could be explained by the secretion of small vesicles by cancer cells, so-called exosomes. Therefore, mass spectrometry and Western blotting analyses of the protein content of exosomes isolated from PCa cell lines was performed. This resulted in the identification of mainly cytoplasmic proteins of which several had previously been identified in the serum of xenografted mice, including proteasome subunits. The isolated exosomes also contained RNA, including the gene fusion TMPRSS2-ERG product. These observations suggest that although their function is not clearly defined cancer-derived exosomes offer possibilities for the identification of novel biomarkers for PCa.
Figures






Similar articles
-
Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013. PLoS One. 2013. PMID: 24391718 Free PMC article.
-
Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.PLoS One. 2016 May 6;11(5):e0154967. doi: 10.1371/journal.pone.0154967. eCollection 2016. PLoS One. 2016. PMID: 27152724 Free PMC article.
-
Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice.Mol Cell Proteomics. 2006 Oct;5(10):1830-9. doi: 10.1074/mcp.M500371-MCP200. Epub 2006 May 19. Mol Cell Proteomics. 2006. PMID: 16714762
-
Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.Mol Cell Proteomics. 2012 Oct;11(10):863-85. doi: 10.1074/mcp.M111.014845. Epub 2012 Jun 21. Mol Cell Proteomics. 2012. PMID: 22723089 Free PMC article.
-
[Exosomes of malignant tumors: prospects of omiсs diagnostics].Biomed Khim. 2019 Oct;65(6):457-467. doi: 10.18097/PBMC20196506457. Biomed Khim. 2019. PMID: 31876516 Review. Russian.
Cited by
-
On the Choice of the Extracellular Vesicles for Therapeutic Purposes.Int J Mol Sci. 2019 Jan 9;20(2):236. doi: 10.3390/ijms20020236. Int J Mol Sci. 2019. PMID: 30634425 Free PMC article. Review.
-
Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles.J Extracell Vesicles. 2017 Aug 10;6(1):1354645. doi: 10.1080/20013078.2017.1354645. eCollection 2017. J Extracell Vesicles. 2017. PMID: 28819549 Free PMC article.
-
Multiple Click-Selective tRNA Synthetases Expand Mammalian Cell-Specific Proteomics.J Am Chem Soc. 2018 Jun 13;140(23):7046-7051. doi: 10.1021/jacs.8b03074. Epub 2018 May 30. J Am Chem Soc. 2018. PMID: 29775058 Free PMC article.
-
Advances in the study of miRNAs in chronic kidney disease with cardiovascular complications.Front Physiol. 2023 Nov 23;14:1283597. doi: 10.3389/fphys.2023.1283597. eCollection 2023. Front Physiol. 2023. PMID: 38074330 Free PMC article. Review.
-
The emerging role of medical foods and therapeutic potential of medical food-derived exosomes.Nanoscale Adv. 2023 Nov 11;6(1):32-50. doi: 10.1039/d3na00649b. eCollection 2023 Dec 19. Nanoscale Adv. 2023. PMID: 38125597 Free PMC article. Review.
References
-
- Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., and Redwine, E. ( 1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317, 909–916 - PubMed
-
- Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., Crowley, J. J., and Coltman, C. A., Jr. ( 2004) Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N. Engl. J. Med. 350, 2239–2246 - PubMed
-
- Mikolajczyk, S. D., and Rittenhouse, H. G. ( 2004) Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease. Rinsho Byori 52, 223–230 - PubMed
-
- Paul, B., Dhir, R., Landsittel, D., Hitchens, M. R., and Getzenberg, R. H. ( 2005) Detection of prostate cancer with a blood-based assay for early prostate cancer antigen. Cancer Res. 65, 4097–4100 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources